Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 13
Original Research
Indacaterol acetate/mometasone furoate provides sustained improvements in lung function compared with salmeterol xinafoate/fluticasone propionate in patients with moderate-to-very-severe COPD: results from a Phase II randomized, double-blind 12-week study
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
10,516 | Dovepress* | 8,475+ | 1,396 | 9,871 | |
PubMed Central* | 2,041 | 359 | 2,400 | ||
Totals | 10,516 | 1,755 | 12,271 | ||
*Since 6 December 2018 |
View citations on PubMed Central and Google Scholar